ANDA 87655, held by Vangard. Hydrochlorothiazide; Spironolactone.
As of Nov 16, 2026, ANDA 87655 (Spironolactone W/ Hydrochlorothiazide), held by Vangard, was first approved by FDA on Dec 14, 1981, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 14, 1981 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Spironolactone W/ Hydrochlorothiazide25MG;25MG ยท tablet;oral | Hydrochlorothiazide; Spironolactone | Discontinued |
| Oct 7, 1987 | Supplement 5Manufacturing | Approved | None posted |
| Dec 14, 1981 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters